GlaxoSmithKline ( (GB:GSK) ) has issued an update.
GSK has announced the repurchase of 808,000 of its ordinary shares as part of its ongoing buyback program. This transaction, facilitated by Citigroup Global Markets Limited, reflects GSK’s strategy to enhance shareholder value and optimize its capital structure. The shares, purchased at prices ranging from 1,413.00p to 1,468.50p, will be held as treasury shares, contributing to a total of 190,303,940 shares in treasury. This move underscores GSK’s commitment to returning value to its shareholders and maintaining a strong financial position.
More about GlaxoSmithKline
GlaxoSmithKline (GSK) is a leading pharmaceutical and healthcare company known for its development and production of vaccines, medicines, and consumer healthcare products. The company operates globally, focusing on innovative solutions in the healthcare sector.
YTD Price Performance: 6.46%
Average Trading Volume: 9,098,893
Technical Sentiment Signal: Hold
Current Market Cap: £57.57B
Learn more about GSK stock on TipRanks’ Stock Analysis page.